Clinical Trials in Boston

Showing 9801-9820 of 13,548 trials

Extended Follow-Up After Islet Transplantation in T1D

NCT01369082

The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.

Type 1 Diabetes (T1D)Islet Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)75 participantsStarted May 2011

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

TERMINATEDPhase 1< 1 mile

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

NCT02872428

THIS IS THE SECOND PART OF A 2-PART STUDY. The purpose of the first part of this study was to determine the safety and tolerability of ascending doses of valproic acid (also known as Depacon) administered as intravenous infusion (IV) in doses ranging from 15 mg/kg to 250 mg/kg in healthy subjects. ID: VPA-C-002 The second part of the study will also be to determine the safety and tolerability of single ascending doses of valproic acid administered as IV in trauma subjects with hemorrhagic shock.

Shock,HemorrhagicTrauma

Dr. Hasan Alam1 participantsStarted Nov 2016

Boston, Massachusetts, United States • Ann Arbor, Michigan, United States

Extended Follow-Up After Islet Transplantation in T1D

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

Find Trials by Condition in Boston

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)

Ablation of Intestinal Metaplasia Containing Dysplasia

Minimally Invasive Closure of Umbilical Hernias

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)